Mirae Asset Global ETFs Holdings
SPRY icon

Mirae Asset Global ETFs Holdings’s ARS Pharmaceuticals SPRY Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$286K Buy
35,867
+1,767
+5% +$16.9K ﹤0.01% 2174
2025
Q4 		$397K Buy
34,100
+438
+1% +$4.26K ﹤0.01% 2003
2025
Q3 		$336K Sell
33,662
-332
-1% -$4.76K ﹤0.01% 2052
2025
Q2 		$596K Buy
33,994
+1,234
+4% +$17.8K ﹤0.01% 1725
2025
Q1 		$412K Sell
32,760
-800
-2% -$9.63K ﹤0.01% 1965
2024
Q4 		$354K Buy
33,560
+3,327
+11% +$46.6K ﹤0.01% 2086
2024
Q3 		$438K Buy
30,233
+14,005
+86% +$167K ﹤0.01% 1983
2024
Q2 		$137K Buy
+16,228
New +$144K ﹤0.01% 2441

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return